世界の粘液型円形細胞脂肪肉腫治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Myxoid Round Cell Liposarcoma Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4546 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User	￥819,000 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、粘液型円形細胞脂肪肉腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トラベクテジン、メクロレタミン、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・粘液型円形細胞脂肪肉腫治療薬の市場動向 ・企業の競争状況、市場シェア ・粘液型円形細胞脂肪肉腫治療薬の種類別市場規模と予測2016-2027（トラベクテジン、メクロレタミン、その他） ・粘液型円形細胞脂肪肉腫治療薬の用途別市場規模と予測2016-2027（病院、在宅医療、専門クリニック、その他） ・粘液型円形細胞脂肪肉腫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・粘液型円形細胞脂肪肉腫治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・粘液型円形細胞脂肪肉腫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・粘液型円形細胞脂肪肉腫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・粘液型円形細胞脂肪肉腫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Adaptimmune、GlaxoSmithKline plc、Merck & Co., Inc、Novartis、Infinity Pharmaceuticals, Inc、Mirati Therapeutics,Inc、Eli Lilly、Recordati SpA） ・結論

Myxoid/round Cell Liposarcoma is also known as myxoliposarcoma is a malignant tumor that occurs in the body’s fat tissue most preferable found in the limbs. It is characterized by unusual pattern of metastasis to extrapulmonary sites. It has been found to be in geriatric male population.

Market Analysis and Insights: Global Myxoid Round Cell Liposarcoma Drug Market
The global Myxoid Round Cell Liposarcoma Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Myxoid Round Cell Liposarcoma Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Myxoid Round Cell Liposarcoma Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Myxoid Round Cell Liposarcoma Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Myxoid Round Cell Liposarcoma Drug market.

Global Myxoid Round Cell Liposarcoma Drug Scope and Market Size
Myxoid Round Cell Liposarcoma Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myxoid Round Cell Liposarcoma Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Drug
Trabectedin
Mechlorethamine
Others
By Therapy
Chemotherapy
Radiation Therapy
Others
By Routes of Administration
Injectable
Oral

Segment by Application
Hospitals
Homecare
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Adaptimmune
GlaxoSmithKline plc
Merck & Co., Inc
Novartis
Infinity Pharmaceuticals, Inc
Mirati Therapeutics,Inc
Eli Lilly
Recordati SpA

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myxoid Round Cell Liposarcoma Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Trabectedin
1.2.3 Mechlorethamine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myxoid Round Cell Liposarcoma Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Myxoid Round Cell Liposarcoma Drug Market Perspective (2016-2027)
2.2 Myxoid Round Cell Liposarcoma Drug Growth Trends by Regions
2.2.1 Myxoid Round Cell Liposarcoma Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Myxoid Round Cell Liposarcoma Drug Historic Market Share by Regions (2016-2021)
2.2.3 Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Regions (2022-2027)
2.3 Myxoid Round Cell Liposarcoma Drug Industry Dynamic
2.3.1 Myxoid Round Cell Liposarcoma Drug Market Trends
2.3.2 Myxoid Round Cell Liposarcoma Drug Market Drivers
2.3.3 Myxoid Round Cell Liposarcoma Drug Market Challenges
2.3.4 Myxoid Round Cell Liposarcoma Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Myxoid Round Cell Liposarcoma Drug Players by Revenue
3.1.1 Global Top Myxoid Round Cell Liposarcoma Drug Players by Revenue (2016-2021)
3.1.2 Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Players (2016-2021)
3.2 Global Myxoid Round Cell Liposarcoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Myxoid Round Cell Liposarcoma Drug Revenue
3.4 Global Myxoid Round Cell Liposarcoma Drug Market Concentration Ratio
3.4.1 Global Myxoid Round Cell Liposarcoma Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myxoid Round Cell Liposarcoma Drug Revenue in 2020
3.5 Myxoid Round Cell Liposarcoma Drug Key Players Head office and Area Served
3.6 Key Players Myxoid Round Cell Liposarcoma Drug Product Solution and Service
3.7 Date of Enter into Myxoid Round Cell Liposarcoma Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Myxoid Round Cell Liposarcoma Drug Breakdown Data by Type
4.1 Global Myxoid Round Cell Liposarcoma Drug Historic Market Size by Type (2016-2021)
4.2 Global Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Type (2022-2027)

5 Myxoid Round Cell Liposarcoma Drug Breakdown Data by Application
5.1 Global Myxoid Round Cell Liposarcoma Drug Historic Market Size by Application (2016-2021)
5.2 Global Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
6.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type
6.2.1 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
6.2.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
6.2.3 North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
6.3 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application
6.3.1 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
6.3.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
6.3.3 North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
6.4 North America Myxoid Round Cell Liposarcoma Drug Market Size by Country
6.4.1 North America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
6.4.2 North America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
7.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type
7.2.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
7.2.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
7.2.3 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
7.3 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application
7.3.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
7.3.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
7.3.3 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
7.4 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country
7.4.1 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
7.4.2 Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
8.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type
8.2.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application
8.3.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region
8.4.1 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
9.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type
9.2.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
9.2.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
9.2.3 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
9.3 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application
9.3.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
9.3.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
9.3.3 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
9.4 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country
9.4.1 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
9.4.2 Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size (2016-2027)
10.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type
10.2.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application
10.3.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country
10.4.1 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Introduction
11.1.4 Johnson & Johnson Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Adaptimmune
11.2.1 Adaptimmune Company Details
11.2.2 Adaptimmune Business Overview
11.2.3 Adaptimmune Myxoid Round Cell Liposarcoma Drug Introduction
11.2.4 Adaptimmune Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.2.5 Adaptimmune Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Introduction
11.3.4 GlaxoSmithKline plc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Company Details
11.4.2 Merck & Co., Inc Business Overview
11.4.3 Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Introduction
11.4.4 Merck & Co., Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.4.5 Merck & Co., Inc Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Myxoid Round Cell Liposarcoma Drug Introduction
11.5.4 Novartis Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Infinity Pharmaceuticals, Inc
11.6.1 Infinity Pharmaceuticals, Inc Company Details
11.6.2 Infinity Pharmaceuticals, Inc Business Overview
11.6.3 Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Introduction
11.6.4 Infinity Pharmaceuticals, Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.6.5 Infinity Pharmaceuticals, Inc Recent Development
11.7 Mirati Therapeutics,Inc
11.7.1 Mirati Therapeutics,Inc Company Details
11.7.2 Mirati Therapeutics,Inc Business Overview
11.7.3 Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Introduction
11.7.4 Mirati Therapeutics,Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.7.5 Mirati Therapeutics,Inc Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Myxoid Round Cell Liposarcoma Drug Introduction
11.8.4 Eli Lilly Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Recordati SpA
11.9.1 Recordati SpA Company Details
11.9.2 Recordati SpA Business Overview
11.9.3 Recordati SpA Myxoid Round Cell Liposarcoma Drug Introduction
11.9.4 Recordati SpA Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
11.9.5 Recordati SpA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Myxoid Round Cell Liposarcoma Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Trabectedin
Table 3. Key Players of Mechlorethamine
Table 4. Key Players of Others
Table 5. Global Myxoid Round Cell Liposarcoma Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Myxoid Round Cell Liposarcoma Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Myxoid Round Cell Liposarcoma Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Myxoid Round Cell Liposarcoma Drug Market Share by Regions (2016-2021)
Table 9. Global Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Myxoid Round Cell Liposarcoma Drug Market Share by Regions (2022-2027)
Table 11. Myxoid Round Cell Liposarcoma Drug Market Trends
Table 12. Myxoid Round Cell Liposarcoma Drug Market Drivers
Table 13. Myxoid Round Cell Liposarcoma Drug Market Challenges
Table 14. Myxoid Round Cell Liposarcoma Drug Market Restraints
Table 15. Global Myxoid Round Cell Liposarcoma Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Myxoid Round Cell Liposarcoma Drug Market Share by Players (2016-2021)
Table 17. Global Top Myxoid Round Cell Liposarcoma Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myxoid Round Cell Liposarcoma Drug as of 2020)
Table 18. Ranking of Global Top Myxoid Round Cell Liposarcoma Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Myxoid Round Cell Liposarcoma Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Myxoid Round Cell Liposarcoma Drug Product Solution and Service
Table 22. Date of Enter into Myxoid Round Cell Liposarcoma Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Myxoid Round Cell Liposarcoma Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Myxoid Round Cell Liposarcoma Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Product
Table 65. Johnson & Johnson Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Adaptimmune Company Details
Table 68. Adaptimmune Business Overview
Table 69. Adaptimmune Myxoid Round Cell Liposarcoma Drug Product
Table 70. Adaptimmune Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 71. Adaptimmune Recent Development
Table 72. GlaxoSmithKline plc Company Details
Table 73. GlaxoSmithKline plc Business Overview
Table 74. GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Product
Table 75. GlaxoSmithKline plc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline plc Recent Development
Table 77. Merck & Co., Inc Company Details
Table 78. Merck & Co., Inc Business Overview
Table 79. Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Product
Table 80. Merck & Co., Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 81. Merck & Co., Inc Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Myxoid Round Cell Liposarcoma Drug Product
Table 85. Novartis Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Infinity Pharmaceuticals, Inc Company Details
Table 88. Infinity Pharmaceuticals, Inc Business Overview
Table 89. Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Product
Table 90. Infinity Pharmaceuticals, Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 91. Infinity Pharmaceuticals, Inc Recent Development
Table 92. Mirati Therapeutics,Inc Company Details
Table 93. Mirati Therapeutics,Inc Business Overview
Table 94. Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Product
Table 95. Mirati Therapeutics,Inc Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 96. Mirati Therapeutics,Inc Recent Development
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 100. Eli Lilly Recent Development
Table 101. Recordati SpA Company Details
Table 102. Recordati SpA Business Overview
Table 103. Recordati SpA Myxoid Round Cell Liposarcoma Drug Product
Table 104. Recordati SpA Revenue in Myxoid Round Cell Liposarcoma Drug Business (2016-2021) & (US$ Million)
Table 105. Recordati SpA Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myxoid Round Cell Liposarcoma Drug Market Share by Type: 2020 VS 2027
Figure 2. Trabectedin Features
Figure 3. Mechlorethamine Features
Figure 4. Others Features
Figure 5. Global Myxoid Round Cell Liposarcoma Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Homecare Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Myxoid Round Cell Liposarcoma Drug Report Years Considered
Figure 11. Global Myxoid Round Cell Liposarcoma Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Myxoid Round Cell Liposarcoma Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Myxoid Round Cell Liposarcoma Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Myxoid Round Cell Liposarcoma Drug Market Share by Regions (2022-2027)
Figure 15. Global Myxoid Round Cell Liposarcoma Drug Market Share by Players in 2020
Figure 16. Global Top Myxoid Round Cell Liposarcoma Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myxoid Round Cell Liposarcoma Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Myxoid Round Cell Liposarcoma Drug Revenue in 2020
Figure 18. Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Myxoid Round Cell Liposarcoma Drug Market Share by Type (2016-2027)
Figure 22. North America Myxoid Round Cell Liposarcoma Drug Market Share by Application (2016-2027)
Figure 23. North America Myxoid Round Cell Liposarcoma Drug Market Share by Country (2016-2027)
Figure 24. United States Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Myxoid Round Cell Liposarcoma Drug Market Share by Type (2016-2027)
Figure 28. Europe Myxoid Round Cell Liposarcoma Drug Market Share by Application (2016-2027)
Figure 29. Europe Myxoid Round Cell Liposarcoma Drug Market Share by Country (2016-2027)
Figure 30. Germany Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Myxoid Round Cell Liposarcoma Drug Market Share by Region (2016-2027)
Figure 40. China Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Myxoid Round Cell Liposarcoma Drug Market Share by Type (2016-2027)
Figure 48. Latin America Myxoid Round Cell Liposarcoma Drug Market Share by Application (2016-2027)
Figure 49. Latin America Myxoid Round Cell Liposarcoma Drug Market Share by Country (2016-2027)
Figure 50. Mexico Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Myxoid Round Cell Liposarcoma Drug Market Share by Country (2016-2027)
Figure 56. Turkey Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Myxoid Round Cell Liposarcoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 60. Adaptimmune Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 62. Merck & Co., Inc Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 64. Infinity Pharmaceuticals, Inc Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 65. Mirati Therapeutics,Inc Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 67. Recordati SpA Revenue Growth Rate in Myxoid Round Cell Liposarcoma Drug Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---